A nine-year old licencing deal signed on behalf of WA medical researchers is continuing to deliver returns, with US company Sarepta Therapeutics paying $11.5 million in royalties last year.
11/03/2022 - 15:24
US drug royalties flow to UWA, Perron
11/03/2022 - 15:24